|
Editorial | Top |
|
|
|
Focus on Antibody Engineering and Manufacture King in the kingdom of uncertainty p1025 doi:10.1038/nbt0905-1025 Full text | PDF
(72K)
|
|
News | Top |
|
|
|
Focus on Antibody Engineering and Manufacture Profile: Lisa Drakeman p1035 Laura DeFrancesco Published online: 31 August 2005 | doi:10.1038/nbt0905-1035 Abstract | Full text | PDF
(59K)
|
|
|
|
News Feature |
|
|
|
Focus on Antibody Engineering and Manufacture The problem with potency pp1037 - 1039 Christopher Thomas Scott Published online: 31 August 2005 | doi:10.1038/nbt0905-1037 Abstract | Full text | PDF
(131K)
|
|
Opinion and Comment | Top |
|
|
|
Commentary |
|
|
|
Focus on Antibody Engineering and Manufacture Empowering the inventorthe case of monoclonal antibodies pp1047 - 1049 Mike Clark doi:10.1038/nbt0905-1047 Abstract | Full text | PDF
(92K)
|
|
|
|
Focus on Antibody Engineering and Manufacture Overhauling oversightEuropean drug legislation pp1050 - 1053 Lincoln Tsang doi:10.1038/nbt0905-1050 Abstract | Full text | PDF
(178K)
|
|
|
|
Focus on Antibody Engineering and Manufacture Flexibilitythe guiding principle for antibody manufacturing pp1054 - 1058 Keith L Carson doi:10.1038/nbt0905-1054 Abstract | Full text | PDF
(1,171K)
|
|
Features | Top |
|
|
|
Focus on Antibody Engineering and Manufacture Upping the ante on antibodies pp1065 - 1072 Monya Baker doi:10.1038/nbt0905-1065 Abstract | Full text | PDF
(198K)
|
|
|
|
Focus on Antibody Engineering and Manufacture Monoclonal antibody successes in the clinic pp1073 - 1078 Janice M Reichert, Clark J Rosensweig, Laura B Faden
& Matthew C Dewitz doi:10.1038/nbt0905-1073 Abstract | Full text | PDF
(276K)
|
|
|
|
Patents |
|
|
|
Focus on Antibody Engineering and Manufacture The patentability of antibodies in the United States pp1079 - 1080 Deborah L Lu, Angela M Collison
& Thomas J Kowalski doi:10.1038/nbt0905-1079 Abstract | Full text | PDF
(44K)
|
|
|
|
Focus on Antibody Engineering and Manufacture Recent patent applications related to antibodies p1081 doi:10.1038/nbt0905-1081 Full text | PDF
(29K)
|
|
Research | Top |
|
|
|
Reviews |
|
|
|
Focus on Antibody Engineering and Manufacture Selecting and screening recombinant antibody libraries pp1105 - 1116 Hennie R Hoogenboom Published online: 07 September 2005 | doi:10.1038/nbt1126 Abstract | Full text | PDF
(2,062K)
|
|
|
|
Focus on Antibody Engineering and Manufacture Human antibodies from transgenic animals pp1117 - 1125 Nils Lonberg Published online: 07 September 2005 | doi:10.1038/nbt1135 Abstract | Full text | PDF
(3,019K)
|
|
|
|
Focus on Antibody Engineering and Manufacture Engineered antibody fragments and the rise of single domains pp1126 - 1136 Philipp Holliger
& Peter J Hudson Published online: 07 September 2005 | doi:10.1038/nbt1142 Abstract | Full text | PDF
(1,892K)
|
|
|
|
Focus on Antibody Engineering and Manufacture Arming antibodies: prospects and challenges for immunoconjugates pp1137 - 1146 Anna M Wu
& Peter D Senter Published online: 07 September 2005 | doi:10.1038/nbt1141 Abstract | Full text | PDF
(1,183K)
|
|
|
|
Focus on Antibody Engineering and Manufacture Monoclonal antibody therapy of cancer pp1147 - 1157 Gregory P Adams
& Louis M Weiner Published online: 07 September 2005 | doi:10.1038/nbt1137 Abstract | Full text | PDF
(4,999K)
|
|
Top |
|
|